Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the rate of major molecular response (MMR) at 12 months after Day 1 initiation of first line treatment with imatinib, in patients randomized at month 3 to treatment with dasatinib 100mg QD or imatinib at any dose, after less than optimal response to 1st line imatinib
Critère d'inclusion
- Chronic Phase Chronic Myeloid Leukemia